Following a surge of over 12% during the regular trading session, Onctic Therapeutics is extending its gains further on the after-hours trading platform NXT.

On the 15th, during the regular session, Onctic Therapeutics closed at 12,050 won, up 1,330 won (12.41%) from the previous trading day. As of 4:02 p.m., the stock was trading at 13,120 won on NXT, up 2,400 won (22.39%), significantly widening its gains compared to the regular session.

The KOSDAQ market also showed strength on the same day. The KOSDAQ index closed at 829.43, surging 45.45 points (5.79%) from the previous trading day, indicating improving investor sentiment. Market attention is now focused on the future stock price trajectory of Onctic Therapeutics.

Previously, Onctic Therapeutics announced through a regulatory filing the day before that no clinically significant drug interactions were observed with the major combination drugs in its Phase 1 clinical trial for JP-1366, a drug candidate currently under development.

[Investors should comprehensively consider the company's regulatory filings, financial performance, and market environment to make prudent investment decisions. This article should be used as reference material for investment decisions.]